coagulation studies lab med

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/61

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

62 Terms

1
New cards

4 stages of the hemostatic mechanism

vasoconstriction, platelet activation, coagulation cascade, fibrinolysis/clot degradation

2
New cards

cells produced from megakaryocytes that live for 7-10days and whose external membranes contain glycoproteins and granules contain hormones, enzymes, and other chemicals

platelets

3
New cards

first role of platelets in primary hemostasis

adhesion (immediatly adhere to expose collagen and von willebrand factor acts as glue to buind platelets to collagen

4
New cards

2nd role of platelets in primary hemostasis

activation (calcoum makes platelets change shape and stick to each other and release their cytoplasmic granules which mediates aggregation.

5
New cards

how long does aspirin inhibit platelet function

for the whole life of the platelet

6
New cards

if your pt is on apririn what should you tell them before their coag studies are done

they need to be off the aspirin for 48-96hrs before hand so their studies dont get messed up

7
New cards

third role of platelets in primary hematostasis

aggregation (platelet recruiting and attach to other platelets to form a mesh network, platelet-to-platelet cross links stabilized by thrombospondin)

8
New cards

what clotting factors are included in the intrinsic pathway

12, 11, 9, 8

9
New cards

what clotting factors are included in the extrinsic pathway

7

10
New cards

what clotting factors are included in the common pathway

10, 5, 7, prothrombin, thrombin, fibrinogen

11
New cards

defects in hemostasis that can result in abnormal bleeding or clotting

injury to vascular system, inadequate platelets in number or fxn, inadequate clotting pathway mech (not enough clotting factors in cascade), inadequate fibrin clot formation, breakdown and repair

12
New cards

whats the first lab test we do for any blood problems/coagulation studies

CBC

13
New cards

possible causes for thrombocytosis (inc platelets)

myoproliferative disorders, reactive from hemorrhage, malignancy, infection, splenectomy

14
New cards

possible causes for thrombocytopenia (dec platelets)

bone marrow disorders, autoimmune disorders, liver disease

15
New cards

skin redness on pts w bleeding disorders doesnt ___

blanch

16
New cards

skin things you may see in pts w thrombocytopenia

petechiae, purpura, ecchymosis (all non-blanching)

17
New cards

most common cause of poor platelet function

secondary to meds (esp aspirin or clopidogrel)

18
New cards

possibel causes for poor platelet function (which may result in life threatning hemorrhages cause they cant clot)

hereditary, myloproliferative diseases, myelodysplastic disorders, uremia, liver dailure, renal failure, clotting factor deficiency

19
New cards

an automated assay of platelet function that measures time required to build a stable platelet plus and obstain full occlusion (simulated in vitro not tested on body) and reported in seconds

closure time

20
New cards

uses for closure time test

good for theraputic monitoring, not a screening test for bleeding risk, prolonged=bad

21
New cards

measurement of PLT aggregation to various activators in vitro that is recorded by a light transmission aggregometer (will initially look turbid and then clear as platelets aggregate)

platelet aggregation studies

22
New cards

how are platelet aggregation studies recorded

change in transmission of light is recorded as a function of time on a moving strip = looks like a response curve

<p>change in transmission of light is recorded as a function of time on a moving strip = looks like a response curve</p>
23
New cards

gold standard in platelet function testing

platelet aggregation studies

24
New cards

the only platelet test that measures platelet function in the body and not in vitro

bleeding time test

25
New cards

a test that measures how long it takes body to stop bleeding by making 2 incisions and recording how long it takes for pt to stop bleeding

bleeding time test

26
New cards

types of coagulation tests

PT, PTT, INR

27
New cards

caogulation test that measures extrinsic and common pathways (factors 2, 5, 7, 10)

prothrombin time (PT)

28
New cards

what increases PT

prolonged in coagulation factor deficiencies

29
New cards

method of choice to monitor warfarin therapy

PT

30
New cards

what is a critical value for International Normalized Ratio (INR)

5+ (want it to be less than 3.5 if theyre on warfarin)

31
New cards

increasing INR=

increased anticoagulation

32
New cards

use for measuring PT

evaluate liver function (bc liver is where coagulation factors are made)

33
New cards

high PT causes

low vit K , liver disease, anti-coag therapy, DIC, hypothermia, massive blood diffusion , meds (erythromycin, allopurinol)

34
New cards

low PT causes

fresh frozen plasma transfusion, vit k supplementation, meds (PCN, doxycycline, rifampin (TB med), aspirin)

35
New cards

coagulation test that measures intrinsic and common pathways (factors 1, 2, 5, 8, 9, 10, 11, 12)

partial thromboplastin time (PTT or APTT)

36
New cards

causes of prolonged/high PTT

coagulation factor deficiency, hereditary, vit k deficiency, liver disease, anti-coagulatoin therapy

37
New cards

causes of shortened/lower PTT

DIC, severe hemorrhage, cancer

38
New cards

critical value for PTT

100+ (indicates bleeding problem, cant clot)

39
New cards

clinical uses of PTT test

eval liver function, monitor heparin therapy, detect factor deficiency, detect lupus anticoagulant, detect specific factor inhibitors, monitor unfractionated heparin therapy, monitor direct thrombin inhibitor

40
New cards

a coagulation test that measures protein concentration (NOT functional activity), usually done when PT/INR and PTT are abnormal or when diagnosing hypo/dysfibrinogenemia/DIC/primary fibronolysis

fibrinogen (factor 1) test

41
New cards

what kind of fibrinogen (factor 1) test is most commonly done

clauss assay is most commpnly performed (modified TT)

42
New cards

critical value for fibrinogen (factor 1) test

under 100

43
New cards

high fibrinogen (factor 1) causes

inflammatory, trauma, cancer, meds (aspirin aka salicylate)

44
New cards

low fibrinogen (factor 1) causes

DIC, liver disease, massive blood transfusion, meds (simvostatin, atenolol, prednisolone)

45
New cards

coag test that measures conversion of fibrinogen to fibrin in the common pathway and is sensitive to circulating anticoagulants (heparin)

thrombin time (TT)

46
New cards

how is a fibrin degradation products test done

serum sample collected in special tubes containing thrombin and a trypsin inhibitor that presents break down of fibrinogen in vitro. serum is added to latex particles coated w anti-fibrinogen antibodies

47
New cards

what do fibrin degradation products cause

visible agglutination

48
New cards

test that detects abnormal clotting in blood (not abnormal bleeding)

D-Dimer assay

49
New cards

how is a D-Dimer assay test done

plasma added to latex particles coated w antibodies specific to D-dimers → causes visible agglutination

50
New cards

negative D-Dimer assay =

clot unlikely (yay)

51
New cards

positive D-Dimer assay =

clot has formed and is breaking down (oh no)

52
New cards

when is a D-Dimer assay test used

when thrombotic event (DVT, PE, etc) suspected or when there are signs of DIC

53
New cards

other things that can falsely raise D-Dimer

preg, heart disease, cancer, recent surgery

54
New cards

which test is best for evaluating a defect in the intrinsic pathway

PTT

55
New cards

first screening tests done when theres bleeding concerns

PT and PTT (if abnormal may be an inhibitor or factor deficiency/abnormality)

56
New cards

what can cause abnormal clot formation

activation of coagulation (surgery/cancer/etc), vascular injury (trauma etc), endothelial cell perturbation (radiation therapy etc), down regulation of coagulation regulatory (inhibitor) systems (APCR, plasmin, etc)

57
New cards

warfarin MOA

inhibits carboxylation of vit K dependent coagulation factors (2, 7, 9, 10)

58
New cards

how do we monitor pts on warfarin

monitor their PT/INR

aim for INR of 2-3 or 3-4 if pt has mechanical prosthetic heart valvues or recurrent systemic embolism

59
New cards

heparin MOA

catalyzes inhibition of thrombin, inhibits factor 10a and 9a, inhibits activation of factor 5 and 7 by thrombin, inhibits activation of platelets

60
New cards

how do we monitor pts on heparin

monitor their PTT (1.5-2.5x pts baseline), can cause heaprin indiced thrombocytopenia if too high

61
New cards

low molecular weight heparin MOA

inactivated factor 10a (but doesnt inactivate thrombin much)

62
New cards

how do we monitor pts on LMWH

monitor by factor 10a inhibition assay